Non-invasive tools for liver injury after chemotherapy
Part of Digestive system clinical trials.
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have received platinum chemotherapy for a solid tumor
- You do not have cirrhosis (scarring of the liver) confirmed by biopsy
- You have not had a liver transplant
- You do not have advanced liver cancer beyond Milan criteria
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a rare liver condition called porto-sinusoidal vascular disorder (PSVD), which affects blood flow in the liver. It aims to learn more about what causes it and how it affects patients over time.
This study compares a newer, less invasive method using an endoscope (EUS-PPG) with a standard catheter method (HVPG) to measure liver pressure in people with advanced liver disease. The goal is to see if the newer method is equally accurate and safer.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
This study uses a special ultrasound with contrast to help tell apart two conditions that cause high blood pressure in the liver: porto-sinusoidal vascular disorder (a rare disease of the liver's small blood vessels) and cirrhosis (scarring of the liver). The test may help avoid the need for a liver biopsy.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
Hear when a new Non-Cirrhotic Portal Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.